Cardiac Implantable Electronic Device (CIED) Research Study
Launched by MEDTRONIC CARDIAC RHYTHM AND HEART FAILURE · Sep 20, 2021
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
The Cardiac Implantable Electronic Device (CIED) Research Study is looking to gather information about heart devices that help manage conditions like arrhythmias (irregular heartbeats), bradycardia (slow heart rate), and tachycardia (fast heart rate). Researchers want to learn more about how these devices are used, the procedures to implant them, and the characteristics of patients who receive them. This information will help improve future heart devices and the procedures used to implant them.
To participate in this study, you need to be at least 18 years old and willing to give your consent to take part. You should also be ready to attend study visits and follow the procedures throughout the data collection period. However, if you have a medical condition that would prevent you from participating or are involved in another study that might interfere with the results, you may not be eligible. If you join the study, you can expect to contribute valuable information that could enhance the care and treatment of patients with heart conditions in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Subject is at least 18 years of age.
- • 2. Subject is willing and able to provide written informed consent.
- • 3. Subject is willing and able to complete the study procedures and visits for the duration of data collection requirements
- Exclusion Criteria:
- • 1. Subject is unwilling or unable to comply with study procedures as defined in the protocol.
- • 2. Subject with a medical condition that precludes the patient from participation in the opinion of the investigator.
- • 3. Subject is enrolled in another study that could confound the results of this study, without documented pre-approval from a Medtronic study manager.
About Medtronic Cardiac Rhythm And Heart Failure
Medtronic Cardiac Rhythm and Heart Failure is a leading division of Medtronic, dedicated to advancing innovative therapies for patients with cardiac rhythm disorders and heart failure. With a commitment to improving patient outcomes, this division focuses on developing cutting-edge medical devices and solutions that enhance the management of arrhythmias and heart failure. Leveraging extensive research and clinical expertise, Medtronic Cardiac Rhythm and Heart Failure aims to transform patient care through evidence-based approaches and a robust pipeline of groundbreaking technologies. Their work not only addresses immediate clinical challenges but also contributes to the long-term health and well-being of individuals with complex cardiac conditions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Lancaster, Pennsylvania, United States
Norfolk, Virginia, United States
Pittsburgh, Pennsylvania, United States
Falls Church, Virginia, United States
Macon, Georgia, United States
Leuven, , Belgium
Portland, Oregon, United States
Charlottesville, Virginia, United States
Gainesville, Florida, United States
Portland, Oregon, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials